Ticker Scorecard - AVIR Basics Company: Atea Pharmaceuticals, Inc. IPO Date: October 30, 2020 Sector: Healthcare Industry: Biotech Market Cap: $260.99M Activated in VL: True Average Daily Range Avg Daily Range: $0.46 | 2.73% Avg Daily Range (30 D): $0.05 | 1.76% Avg Daily Range (90 D): $0.06 | 1.96% Institutional Daily Volume Avg Daily Volume: .74M Avg Daily Volume (30 D): .33M Avg Daily Volume (90 D): .28M Trade Size Avg Trade Size (Sh.): 120 Avg Trade Size (Sh.) (30 D): 144 Avg Trade Size (Sh.) (90 D): 133 Institutional Trades Total Inst.Trades: 736 Avg Inst. Trade: $1.97M Avg Inst. Trade (30 D): $.69M Avg Inst. Trade (90 D): $1.33M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.59M Avg Closing Trade (30 D): $.53M Avg Closing Trade (90 D): $1.05M Avg Closing Volume: 182.9K     News Nov 15, 2024 @ 4:00 PM Atea Pharmaceuticals Presents Multiple New Dataset... Source: Atea Pharmaceuticals Oct 16, 2024 @ 6:48 PM ZBH Gears Up for Q3 Earnings: What Lies Ahead for ... Source: Zacks May 29, 2024 @ 11:00 AM Atea Pharmaceuticals to Present at the Jefferies H... Source: Atea Pharmaceuticals, Inc. May 22, 2024 @ 11:00 AM Atea Pharmaceuticals Presents New Data Showcasing ... Source: Atea Pharmaceuticals, Inc. Apr 29, 2024 @ 11:00 AM Atea Announces Presentation of Data Highlighting F... Source: Atea Pharmaceuticals, Inc. Financials   TTM Q3 2024 Q2 2024 Basic EPS $-2.07 $-.37 $-.48 Diluted EPS $-2.07 $-.37 $-.48 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -174.01M $ -31.15M $ -40.52M Operating Income / Loss $ -200.5M $ -37.2M $ -46.92M Cost of Revenue $ $ $ Net Cash Flow $ -39.42M $ -144.93M $ 82.48M PE Ratio     Splits Feb 14, 2018:   11:1